metformin has been researched along with epidermal growth factor in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chessebeuf-Padieu, M; el Baraka, M; Padieu, P; Rapin, JR; Wiernsperger, N; Zaïbi, MS | 1 |
| Abdollahi, M; Hadjibabaie, M; Larijani, B; Mojtahedi, A; Radfar, M; Rajabipour, B | 1 |
| Algire, C; Amrein, L; Birman, E; Deschênes-Simard, X; Ferbeyre, G; Moiseeva, O; Petruccelli, L; Pollak, MN; Viollet, B | 1 |
| Brunicardi, FC; Liu, SH; Nemunaitis, J; Ricordi, C; Rozengurt, E; Sanchez, R; Sinnett-Smith, J; Wang, A; Wu, J; Yu, J; Zhou, G | 1 |
| Faggi, L; Giustina, A; Tulipano, G | 1 |
| Culig, Z | 1 |
1 review(s) available for metformin and epidermal growth factor
| Article | Year |
|---|---|
Epithelial mesenchymal transition and resistance in endocrine-related cancers.
Topics: Benzopyrans; Breast Neoplasms; Cadherins; Cell Plasticity; Cytokines; Disease Progression; Epidermal Growth Factor; Epithelial-Mesenchymal Transition; Female; Humans; Inflammation; Male; MAP Kinase Kinase 5; Metformin; MicroRNAs; Prostatic Neoplasms; Proto-Oncogene Proteins c-fos; Receptor, ErbB-2; Signal Transduction; Transforming Growth Factor beta | 2019 |
1 trial(s) available for metformin and epidermal growth factor
| Article | Year |
|---|---|
Effects of pentoxifylline on oxidative stress and levels of EGF and NO in blood of diabetic type-2 patients; a randomized, double-blind placebo-controlled clinical trial.
Topics: Diabetes Mellitus, Type 2; Double-Blind Method; Epidermal Growth Factor; Female; Free Radical Scavengers; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipid Peroxidation; Male; Metformin; Middle Aged; Nitric Oxide; Oxidative Stress; Pentoxifylline; Sulfonylurea Compounds; Thiobarbituric Acid Reactive Substances; Time Factors; Treatment Outcome | 2005 |
4 other study(ies) available for metformin and epidermal growth factor
| Article | Year |
|---|---|
Metformin induces an agonist-specific increase in albumin production by primary cultured rat hepatocytes.
Topics: Albumins; Animals; Body Weight; Cell Survival; Cells, Cultured; Epidermal Growth Factor; Insulin; Insulin-Like Growth Factor I; Liver; Male; Metformin; Rats; Rats, Wistar; Time Factors | 1995 |
Metformin reduces endogenous reactive oxygen species and associated DNA damage.
Topics: Adenylate Kinase; Animals; Cell Line; Diabetes Mellitus, Type 2; DNA Damage; Enzyme-Linked Immunosorbent Assay; Epidermal Growth Factor; Fibroblasts; Flow Cytometry; Humans; Hydrogen Peroxide; Hypoglycemic Agents; Insulin; Male; Metformin; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Mutagenesis; Mutation; NADP; Reactive Oxygen Species | 2012 |
Metformin Restrains Pancreatic Duodenal Homeobox-1 (PDX-1) Function by Inhibiting ERK Signaling in Pancreatic Ductal Adenocarcinoma.
Topics: Adenocarcinoma; Carcinoma, Pancreatic Ductal; Cell Line; Cell Line, Tumor; Diabetes Mellitus, Type 2; Down-Regulation; Epidermal Growth Factor; Extracellular Signal-Regulated MAP Kinases; Genes, Homeobox; HEK293 Cells; Homeodomain Proteins; Humans; MAP Kinase Signaling System; Metformin; Pancreas; Pancreatic Neoplasms; Protein Kinase Inhibitors; Signal Transduction; Trans-Activators | 2016 |
Effects of metformin on cell growth and AMPK activity in pituitary adenoma cell cultures, focusing on the interaction with adenylyl cyclase activating signals.
Topics: Adenylate Kinase; Adenylyl Cyclases; Aminoimidazole Carboxamide; AMP-Activated Protein Kinases; Animals; Apoptosis; Cell Proliferation; Cell Survival; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Epidermal Growth Factor; Extracellular Signal-Regulated MAP Kinases; Growth Hormone-Releasing Hormone; Humans; Metformin; Phosphorylation; Pituitary Neoplasms; Rats; Ribonucleotides; Ribosomal Protein S6; Signal Transduction; Stress, Physiological; Tumor Cells, Cultured | 2018 |